Study Evaluating Single Doses of BLI-489 in Healthy Subjects

NCT00820404 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: BLI-489
DRUG: Placebo

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer